The difference is FDA approval: Mounjaro is approved for type 2 diabetes, and Zepbound is approved for chronic weight management
no deadline for HSAs)
Bottom line Managing digestive side effects from GLP-1 medications can feel frustrating, but support is available
While a lack of genetic association does not exclude therapeutic potential, it lowers confidence when other indicators are weak
For example, in the SURMOUNT-4 trial, tirzepatide discontinuers were randomized to a placebo, and they were unaware whether they were receiving tirzepatide or not. In real-world settings, the most common reasons for discontinuation are cost or insurance-related issues, and side effects, with the former predominating, he added
Multi-Pathway Brightening: It addresses skin tone by inhibiting tyrosinase activity and shifting melanin production from dark eumelanin to lighter pheomelanin